• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Annexon, Inc. - common stock (NQ: ANNX )

    5.260 +0.030 (+0.57%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 546,028
    Open 5.130
    Bid (Size) 5.050 (2)
    Ask (Size) 5.300 (75)
    Prev. Close 5.230
    Today's Range 5.090 - 5.300
    52wk Range 3.860 - 8.400
    Shares Outstanding 47,722,995
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Announces Positive Topline Results from Real-World Evidence Study Comparing ANX005 Treatment to Intravenous Immunoglobulin (IVIg) or Plasma Exchange (PE) in a Matched Patient Cohort for the Treatment of Guillain-Barré Syndrome (GBS)
    From Annexon Biosciences
    Via GlobeNewswire

    Performance

    YTD
    +8.68%
    +8.68%
    1 Month
    -0.57%
    -0.57%
    3 Month
    -14.05%
    -14.05%
    6 Month
    +9.13%
    +9.13%
    1 Year
    +13.61%
    +13.61%

    More News

    Read More
    Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in Geographic Atrophy at the Floretina-ICOOR 2024 Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    ANNX Stock Earnings: Annexon Meets EPS for Q2 2024
    Via InvestorPlace
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Biosciences to Present at the Jefferies London Healthcare Conference
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Presents Phase 2 Vision Preservation Data with ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon to Present New Phase 2 ARCHER Data for ANX007 in Dry AMD Patients with Less Advanced GA at the American Academy of Ophthalmology 2024 Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in GA at the Retina Society 57th Annual Meeting and 24th Euretina Congress
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Expands Senior Leadership in Commercial, Medical Affairs and Health Economics to Advance Global Late-Stage Neuroinflammatory-Targeted Portfolio
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Biosciences to Participate in Upcoming September Investor Conferences
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Second Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Provides Update on ARCHER II Global Registrational Program in Geographic Atrophy
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Bank of New York Mellon Posts Upbeat Earnings, Joins Archer Aviation, Rivian Automotive And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Annexon to Present Additional Phase 2 Data Showing Preservation of Visual Function and Structure by ANX007 in Geographic Atrophy at the 42nd ASRS Annual Scientific Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    7 Top Stocks Under $10: June 2024 Edition
    Via InvestorPlace
    Annexon To Present Pivotal Phase 3 Data On Early And Durable Benefits With First-In-Class C1q Blocking Antibody ANX005 In Guillain-Barré Syndrome At 2024 PNS Annual Meeting
    From Annexon Biosciences
    Via GlobeNewswire
    Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
    From Annexon Biosciences
    Via GlobeNewswire
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.